We are live on ! Find out more
Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $80.2B
1-Year Est. Return 50.57%
This Fund
S&P 500
This Quarter Est. Return
+13.37%
1 Year Est. Return
+50.57%
3 Year Est. Return
+139.18%
5 Year Est. Return
+175.96%
10 Year Est. Return
AUM
$67.4B
AUM Growth
+$7.41B
Cap. Flow
+$633M
Cap. Flow %
0.94%
Top 10 Hldgs %
30.51%
Holding
1,260
New
116
Increased
460
Reduced
490
Closed
112

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$905M
2
ABBV icon
AbbVie
ABBV
+$681M
3
AVGO icon
Broadcom
AVGO
+$666M
4
AAPL icon
Apple
AAPL
+$629M
5
LLY icon
Eli Lilly
LLY
+$594M

Sector Composition

Rank Sector Weight
1 Technology 33.89%
2 Consumer Discretionary 13.98%
3 Healthcare 11.36%
4 Communication Services 7.54%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNM icon
1076
Core & Main
CNM
$8.66B
$362K ﹤0.01%
5,998
-1,621
-21% -$86.7K
CROX icon
1077
Crocs
CROX
$6.68B
$349K ﹤0.01%
3,445
-12
-0.3% -$1.22K
GPRE icon
1078
Green Plains
GPRE
$1.06B
$347K ﹤0.01%
57,618
OTEX icon
1079
Open Text
OTEX
$6.08B
$346K ﹤0.01%
11,870
-626
-5% -$17K
JKHY icon
1080
Jack Henry & Associates
JKHY
$11B
$343K ﹤0.01%
1,903
-39
-2% -$6.92K
ZD icon
1081
Ziff Davis
ZD
$1.99B
$339K ﹤0.01%
11,208
WFG icon
1082
West Fraser Timber
WFG
$5.53B
$338K ﹤0.01%
4,617
HGV icon
1083
Hilton Grand Vacations
HGV
$3.33B
$337K ﹤0.01%
8,108
-42,234
-84% -$1.59M
SYRE icon
1084
Spyre Therapeutics
SYRE
$9.27B
$331K ﹤0.01%
22,136
-590
-3% -$8.73K
CSL icon
1085
Carlisle Companies
CSL
$15.2B
$327K ﹤0.01%
877
-3,374
-79% -$1.25M
ARTNA icon
1086
Artesian Resources
ARTNA
$353M
$325K ﹤0.01%
9,695
-2,778
-22% -$94.2K
UEIC icon
1087
Universal Electronics
UEIC
$67.3M
$323K ﹤0.01%
48,753
JAMF
1088
DELISTED
Jamf
JAMF
$322K ﹤0.01%
+33,820
New +$363K
ETR icon
1089
Entergy
ETR
$49.3B
$301K ﹤0.01%
3,622
-797,510
-100% -$65.9M
PFS icon
1090
Provident Financial Services
PFS
$3.16B
$297K ﹤0.01%
16,952
-63,606
-79% -$1.06M
OMCL icon
1091
Omnicell
OMCL
$1.71B
$292K ﹤0.01%
9,933
-100,627
-91% -$3.01M
RBBN icon
1092
Ribbon Communications
RBBN
$372M
$281K ﹤0.01%
70,123
-8,207
-10% -$29.6K
PMVP icon
1093
PMV Pharmaceuticals
PMVP
$62.4M
$279K ﹤0.01%
263,059
+148,021
+129% +$145K
OSBC icon
1094
Old Second Bancorp
OSBC
$1.28B
$271K ﹤0.01%
15,280
-164,300
-91% -$2.68M
KN icon
1095
Knowles
KN
$3.31B
$267K ﹤0.01%
15,126
EGAN icon
1096
eGain
EGAN
$203M
$266K ﹤0.01%
42,630
TBPH icon
1097
Theravance Biopharma
TBPH
$876M
$264K ﹤0.01%
+23,980
New +$233K
ACRS icon
1098
Aclaris Therapeutics
ACRS
$854M
$262K ﹤0.01%
184,585
-496,968
-73% -$672K
IPI icon
1099
Intrepid Potash
IPI
$491M
$257K ﹤0.01%
7,183
STLA icon
1100
Stellantis
STLA
$21.2B
$250K ﹤0.01%
25,057
+2,783
+12% +$27.4K

Similar funds

Assenagon Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Assenagon Asset Management held 1,260 positions worth $67.4B, up 12% from $59.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Assenagon Asset Management's Q2 2025 filing shows 116 new, 460 increased, 490 reduced and 112 closed positions. Its largest new stake was Alibaba: 2,006,591 shares worth $228M. The largest sale was NVIDIA, an estimated $2.35B.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Assenagon Asset Management's largest Q2 2025 buy was Alibaba: 2,006,591 shares worth $228M.
  • Assenagon Asset Management added most to Adobe in Q2 2025, an estimated $905M increase.
  • Assenagon Asset Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $2.35B.
  • Assenagon Asset Management fully exited The AZEK Co in Q2 2025, selling an estimated $54.6M.
  • Assenagon Asset Management's ten largest holdings make up 31% of its $67.4B portfolio in Q2 2025.
  • Assenagon Asset Management opened 116 new positions and closed 112 in Q2 2025.
  • Assenagon Asset Management's portfolio value rose 12% quarter-over-quarter to $67.4B.

Based on Assenagon Asset Management's 13F filing for Q2 2025, filed 11 Jul 2025.